z-logo
Premium
Effect of Photobiomodulation Therapy on the Increase of Viability and Proliferation of Human Mesenchymal Stem Cells
Author(s) -
PasternakMnich Kamila,
Ziemba Barbara,
Szwed Aleksandra,
Kopacz Karolina,
Synder Marek,
Bryszewska Maria,
Kujawa Jolanta
Publication year - 2019
Publication title -
lasers in surgery and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 112
eISSN - 1096-9101
pISSN - 0196-8092
DOI - 10.1002/lsm.23107
Subject(s) - mesenchymal stem cell , viability assay , irradiation , flow cytometry , stem cell , cell growth , chemistry , bone marrow , in vitro , biomedical engineering , cell , biophysics , materials science , microbiology and biotechnology , pathology , biology , medicine , biochemistry , physics , nuclear physics
Background and Objectives We have investigated how low intensity laser irradiation emitted by a multiwave‐locked system (MLS M1) affects the viability and proliferation of human bone marrow mesenchymal stem cells (MSCs) depending on the parameters of the irradiation. Study Design/Materials and Methods Cells isolated surgically from the femoral bone during surgery were identified by flow cytometry and cell differentiation assays. For irradiation, two wavelengths (808 and 905 nm) with the following parameters were used: power density 195, 230, and 318 mW/cm 2 , doses of energy 3, 10, and 20 J (energy density 0.93–6.27 J/cm 2 ), and in continuous (CW) or pulsed emission (PE) (frequencies 1,000 and 2,000 Hz). Results There were statistically significant increases of cell viability and proliferation after irradiation at 3 J (CW; 1,000 Hz), 10 J (1,000 Hz), and 20 J (2,000 Hz). Conclusions Irradiation with the MLS M1 system can be used in vitro to modulate MSCs in preparation for therapeutic applications. This will assist in designing further studies to optimize the radiation parameters and elucidate the molecular mechanisms of action of the radiation. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here